LFpeptides have antibacterial activity against several pathogenic bacteria; however, the 39 exact mechanism of action has not been established. Here, we report the effects of Escherichia coli is a species of the genus Escherichia that contains mostly motile gram-58 negative bacilli that fall within the family Enterobacteriaceae (Nataro and Kaper 1998 
97
We have previously reported that bLF and its synthetic derived peptides, LFcin17-30, or 20 µM bLF. The effects of 50 µg/ml cecropin 1 or 50 µM magainin II were also tested.
157
Untreated bacteria in LB medium were used as a control of growth (viability), and bacteria 158 treated with 100 µg/ml amikacin or ciprofloxacin were used as a positive control of growth 159 inhibition. MICs and CFU/ml were determined using the broth microdilution method growth by LFchimera was similar to that of ciprofloxacin (Fig. 1, panel C) . The peptides 239 magainin II and amikacin had no effect on EAEC viability at the concentrations and 240 conditions used here (data not shown).
242
The greater antimicrobial efficacy exhibited by LFchimera compared to its peptides 
332
Regarding the results reported here (Fig 2) , the cytoplasmic localization of the 
